| Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis A Domnich, L Arata, D Amicizia, J Puig-Barberà, R Gasparini, D Panatto Vaccine 35 (4), 513-520, 2017 | 244 | 2017 |
| Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines D Amicizia, A Domnich, D Panatto, PL Lai, ML Cristina, U Avio, ... Human vaccines & immunotherapeutics 9 (5), 1163-1171, 2013 | 235 | 2013 |
| Socioeconomic impact of influenza on healthy children and their families N Principi, S Esposito, P Marchisio, R Gasparini, P Crovari The Pediatric infectious disease journal 22 (10), S207-S210, 2003 | 221 | 2003 |
| MF59®-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults A Banzhoff, R Gasparini, F Laghi-Pasini, T Staniscia, P Durando, ... PloS one 4 (2), e4384, 2009 | 214 | 2009 |
| Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy F Ansaldi, B Bruzzone, S Salmaso, MC Rota, P Durando, R Gasparini, ... Journal of medical virology 76 (3), 327-332, 2005 | 212 | 2005 |
| The “healthy immigrant” effect: does it exist in Europe today? A Domnich, D Panatto, R Gasparini, D Amicizia Italian Journal of Public Health 9 (3), 2012 | 170 | 2012 |
| Assessing Ebola-related web search behaviour: insights and implications from an analytical study of Google Trends-based query volumes C Alicino, NL Bragazzi, V Faccio, D Amicizia, D Panatto, R Gasparini, ... Infectious diseases of poverty 4, 1-13, 2015 | 168 | 2015 |
| Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy P Durando, F Ansaldi, P Oreste, P Moscatelli, L Marensi, C Grillo, ... Weekly releases (1997–2007) 12 (23), 3212, 2007 | 159 | 2007 |
| Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly R Gasparini, D Amicizia, PL Lai, D Panatto Human Vaccines & Immunotherapeutics 8 (1), 21-28, 2012 | 158 | 2012 |
| Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A (H3N2) drifted influenza viruses F Ansaldi, S Bacilieri, P Durando, L Sticchi, L Valle, E Montomoli, G Icardi, ... Vaccine 26 (12), 1525-1529, 2008 | 153 | 2008 |
| Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects R Gasparini, T Pozzi, E Montomoli, E Fragapane, F Senatore, M Minutello, ... European journal of epidemiology 17, 135-140, 2001 | 140 | 2001 |
| Burden of influenza in healthy children and their households N Principi, S Esposito, R Gasparini, P Marchisio, P Crovari Archives of disease in childhood 89 (11), 1002-1007, 2004 | 138 | 2004 |
| Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies D Panatto, D Amicizia, C Trucchi, F Casabona, PL Lai, P Bonanni, ... BMC public health 12, 1-9, 2012 | 97 | 2012 |
| Meningococcal glycoconjugate vaccines R Gasparini, D Panatto Human vaccines 7 (2), 170-182, 2011 | 91 | 2011 |
| Development and validation of the Italian version of the Mobile Application Rating Scale and its generalisability to apps targeting primary prevention A Domnich, L Arata, D Amicizia, A Signori, B Patrick, S Stoyanov, L Hides, ... BMC Medical Informatics and Decision Making 16, 1-10, 2016 | 90 | 2016 |
| Diet and antibody response to vaccinations in healthy infants G Zoppi, F Mantovanelli, R Astolfi, R Gasparini, L Gobio-Casali, P Crovari The Lancet 322 (8340), 11-14, 1983 | 89 | 1983 |
| The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model S Aballéa, J Chancellor, M Martin, P Wutzler, F Carrat, R Gasparini, ... Value in Health 10 (2), 98-116, 2007 | 84 | 2007 |
| The health care burden and societal impact of acute otitis media in seven European countries: results of an Internet survey JH Wolleswinkel-van den Bosch, EA Stolk, M Francois, R Gasparini, ... Vaccine 28, G39-G52, 2010 | 83 | 2010 |
| Evaluation of in vitro efficacy of the disinfectant Virkon R Gasparini, T Pozzi, R Magnelli, D Fatighenti, E Giotti, G Poliseno, ... European journal of epidemiology 11, 193-197, 1995 | 83 | 1995 |
| An overview on the implementation of HPV vaccination in Europe P Bonanni, M Levi, NB Latham, A Bechini, E Tiscione, P Lai, D Panatto, ... Human Vaccines 7 (sup1), 128-135, 2011 | 82 | 2011 |
Giorgio GuzzettaResearcher, Fondazione Bruno Kessler在 fbk.eu 的电子邮件经过验证
